To provide a peptide and a vaccine which can effectively induce a cytotoxic T lymphocyte to an Ebola virus antigen and can be expected to have a therapeutic effect or a preventive effect on Ebola virus infection and diseases caused by the infection.
The vaccine contains: a peptide which can induce a cytotoxic T lymphocyte restricted to HLA-A*0201, having an amino acid sequence represented by a specific sequence and an amino acid length of 9 to 11; or a liposome to which the peptide is bonded, containing a phospholipid having an acryl group with one unsaturated bond and a carbon number of 14 to 24 or a hydrocarbon group with one unsaturated bond and a carbon number of 14 to 24 and a stabilizer for the liposome, wherein the peptide is bonded to the surface of the liposome.
UCHIDA TETSUYA
TANEICHI MAIKO
MIKUMA AI
YOKOYAMA SHOICHI
NAT INST INFECTIOUS DISEASES
NOF CORP
Kyoko Doi
Mitsunori Kamata
Yaeko Tamura
Kenji Yamamoto
Murata Miyuki
Junzo Koike
Next Patent: ARYLAMINO HETEROCYCLIC CARBOXAMIDE COMPOUND